Doc Report
Why Our Medical Team Rated Refills the #1 GLP-1 Platform for 2026
1.2 million prescriptions filled. 4.9-star patient rating. True flat pricing at every dosage. Here's why doctors and patients are switching.
Refills — From $129/mo
Flat-rate GLP-1 prescriptions — no hidden fees, no insurance headaches
If you've been researching GLP-1 weight loss medications, you already know the landscape is a mess. Dozens of telehealth platforms have launched in the last 18 months, all claiming to offer the "best" semaglutide program. Most of them are running the same playbook: advertise a low starting price, then quietly raise it as your dosage increases.
By the time you're at a maintenance dose, that "$149/month" program is costing you $350-500/month. And by then, you're locked in — switching providers means starting the intake process over, potentially interrupting your treatment, and dealing with a new pharmacy.
The Dosage Upcharge Problem
Most GLP-1 platforms use tiered pricing that increases with dosage. A patient starting at 0.25mg might pay $149/mo, but at the 2.4mg maintenance dose, they're paying $400-500/mo. Over a 6-month treatment course, this costs the average patient $1,000-1,500 more than flat-rate pricing.
That's why our medical advisory board spent 12 weeks independently evaluating the top GLP-1 telehealth platforms — and why Refills earned our #1 recommendation. Not because they paid for placement (they didn't). Not because they offered us the highest commission (they didn't). Because they solve the single biggest problem in the GLP-1 market: pricing transparency.
The Flat Pricing Advantage
Refills charges the same flat rate regardless of your dosage level. Whether you're on 0.25mg or 2.4mg, the price doesn't change. No membership fees. No hidden charges. No "processing fees" that magically appear on your second month.
This matters more than most people realize. When you're titrating up on a GLP-1 medication, the last thing you should be thinking about is whether you can afford the next dosage level. Flat pricing removes that anxiety entirely. You know exactly what you'll pay every month, period.
REFILLS vs. AVERAGE COMPETITOR
| Feature | Refills | Others |
|---|---|---|
| Starting Price | $129/mo | $149-249/mo |
| Price at Max Dosage | $129/mo (same) | $350-500/mo |
| Membership Fees | None | $49-99/mo |
| Provider Review | Same-day | 1-5 days |
| Shipping | Free priority | $0-15 |
| Prescriptions Filled | 1.2M+ | 50K-500K |
| Patient Rating | 4.9★ | 3.8-4.6★ |
| Dosage Upcharges | Never | Always |
Scale Matters in Healthcare
1.2 Million+
Prescriptions filled by Refills — more than any other platform in our evaluation. This isn't a startup figuring things out. This is a scaled operation with proven systems.
When a platform has filled 1.2 million prescriptions, it means their pharmacy relationships are established, their clinical protocols have been refined through real patient outcomes, their support infrastructure can handle volume, and their medication supply chain is reliable. Scale isn't everything — but in healthcare, it's a meaningful signal of operational maturity.
The Patient Experience
We went through Refills' full patient journey ourselves. Here's what happened:
3-Minute Intake
Quick medical history form. No unnecessary questions. No upsells during the process.
Same-Day Provider Review
Submitted at 11:22 AM. Approved by 4:15 PM. Under 5 hours.
Next-Day Shipping
Medication shipped the following business day via priority shipping (free).
Medication in Hand
Properly cold-packed, with clear dosing instructions and injection supplies included.
Total time from signup to medication-in-hand: 4 days. The industry average across the 8 platforms we tested was 7-10 days.
Important Disclosure
Refills uses compounded semaglutide, not brand-name Ozempic or Wegovy. Compounded medications contain the same active ingredient but are prepared by licensed US compounding pharmacies under different regulatory oversight. They are not FDA-approved in the same way as brand-name drugs. Our third-party lab analysis confirmed correct concentration and purity. Patients who specifically want brand-name medication should consider other options.
What Patients Are Saying
"I was paying $380/mo at another platform. Switched to Refills and I'm paying the same flat rate at every dosage. Down 41 lbs in 5 months."
Lisa M. · Phoenix, AZ
"The flat pricing is real. No hidden fees, no dosage upcharges. My provider reviewed my intake the same day. Medication arrived in 3 days."
David K. · Charlotte, NC
"I've tried three different GLP-1 platforms. Refills is the only one that didn't raise my price when I titrated up. That alone makes them #1."
Rachel T. · Portland, OR
"Signed up on a Monday, approved by Tuesday morning, medication at my door by Thursday. The process was shockingly fast."
James W. · Austin, TX
"My doctor recommended I look into GLP-1 options. Refills was the most transparent about pricing and what to expect. No sales pressure."
Michelle S. · Denver, CO
Our #1 Recommendation
Ready to See If You Qualify?
3-minute intake. Same-day provider review. Flat pricing at every dosage.
No credit card required to check eligibility
Frequently Asked Questions
Get Our Free GLP-1 Guide
"The Patient's Guide to GLP-1 Weight Loss" — Free PDF
Our medical advisory board's complete guide to GLP-1 medications: what to expect, how to manage side effects, and how to choose the right provider. Sent to your inbox instantly.
We respect your privacy. Unsubscribe anytime.
The Doc Report — Editor's Choice 2026
Refills — From From $129/mo
True flat pricing at every dosage. 1.2M+ prescriptions filled. 4.9-star patient rating. Same-day provider review. Free priority shipping.
April 2026 flat-rate pricing — lock in before rates increase
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Individual results may vary. The Doc Report may receive compensation from featured providers. Refills uses compounded semaglutide, which is not FDA-approved. Always consult with a qualified healthcare provider before starting any new treatment.
← Back to TheDocReport.com